Flu and RSV are packing a post-holiday one-two punch, sending people into Erie's emergency departments and medical offices ...

The 30-day risks of hospitalization were 17.5%, 15.9%, and 14.4% for COVID, influenza, and RSV, respectively, during the 2022 ...

In the wake of multiple cases of human metapneumovirus (hMPV) in India, multiple questions about its causes and symptoms seem ...

The UKHSA has noted that COVID symptoms have evolved over time. Many individuals now exhibit cold-like symptoms, but others ...

Four viruses are circulating in the U.S., sparking concerns of a possible “quademic." Here's what to know about risk factors ...

RSV is usually contagious for three to eight days. A patient also may be contagious a day or two before experiencing symptoms ...

The novel treatment consists of a single shot which is made of special proteins called antibodies that bind to the site at ...

The estimated effectiveness of the respiratory syncytial virus (RSV) among older US veterans in the 2023-2024 respiratory ...

As of Jan. 20, the CDC reports that RSV activity has peaked in most of the U.S., particularly among young children—a group ...

Shionogi’s respiratory syncytial virus (RSV) antiviral for adults has proven its ability to reduce viral load in a phase 2 ...

A virus rapidly spreading in China is also circulating in the United States, causing concern among health experts.

The prescribing information for two respiratory syncytial virus (RSV) vaccines will now include a warning for the increased ...